21 CFR 522.1883

§ 522.1883 Prednisolone sodium phosphate.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.1883, § 522.1883 Prednisolone sodium phosphate, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87518
Permanent ID: ys:prov:87518@1
SHA-256: f2e1cffa7c3863ee9d08d66a9700f050688d8789079d328ed5018be6eedee2c4

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 20 milligrams (mg) prednisolone sodium phosphate (equivalent to 14.88 mg of prednisolone). (b) Sponsor. See No. 061133 in § 510.600(c) of this chapter. (c) Conditions of use in dogs—(1) Amount. Administer intravenously in a dosage of 2 1/2 to 5 mg per pound of body weight, initially for shock and shock-like states, followed by equal maintenance doses at 1-, 3-, 6-, or 10-hour intervals as determined by the condition of the animal. (2) Indications for use. Administer when a rapid adrenal glucocorticoid and/or anti-inflammatory effect is necessary. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.